Avelox and Deafness neurosensory - a phase IV clinical study of FDA data

Summary:

Deafness neurosensory is reported as a side effect among people who take Avelox (moxifloxacin hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Levaquin, and have Sleep disorder.

The phase IV clinical study analyzes which people have Deafness neurosensory when taking Avelox. It is created by eHealthMe based on reports of 27,890 people who have side effects when taking Avelox from the FDA, and is updated regularly.

What is Avelox?

Avelox has active ingredients of moxifloxacin hydrochloride. It is often used in sinusitis. eHealthMe is studying from 28,651 Avelox users. Check the latest studies of Avelox.

What is Deafness neurosensory?

Deafness neurosensory is found to be associated with 521 drugs and 947 conditions by eHealthMe. Check the latest studies of Deafness neurosensory.

On Jul, 18, 2026

27,890 people reported to have side effects when taking Avelox.
Among them, 29 people (0.1%) have Deafness neurosensory.

Could Avelox cause Deafness neurosensory?

Among these 29 people:

How long have people been on Avelox when they have Deafness neurosensory? *

What is the gender of people who have Deafness neurosensory when taking Avelox? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Deafness neurosensory when taking Avelox? *

What are other drugs people take besides Avelox? *

Zometa: 18 people, 62.07%
Aredia: 18 people, 62.07%
Levaquin: 18 people, 62.07%
Lortab: 17 people, 58.62%
Warfarin Sodium: 17 people, 58.62%
Ambien: 16 people, 55.17%
Lipitor: 16 people, 55.17%
Lexapro: 16 people, 55.17%
Chlorhexidine Gluconate: 16 people, 55.17%
Diazepam: 16 people, 55.17%

What are other side effects people have besides Deafness neurosensory? *

Cellulitis (infection under the skin): 19 people, 65.52%
Dyspnea (difficult or laboured breathing): 19 people, 65.52%
Pleural Effusion (water on the lungs): 19 people, 65.52%
Back Pain: 19 people, 65.52%
Dizziness: 19 people, 65.52%
Pain: 19 people, 65.52%
Stress And Anxiety: 18 people, 62.07%
Intervertebral Disc Degeneration (spinal disc degeneration): 18 people, 62.07%
Osteomyelitis (infection of bone): 18 people, 62.07%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 18 people, 62.07%

What are the existing conditions these people have? *

Sleep Disorder: 15 people, 51.72%
Nausea (feeling of having an urge to vomit): 14 people, 48.28%
Muscle Spasms (muscle contraction): 14 people, 48.28%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 14 people, 48.28%
Depression: 14 people, 48.28%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 14 people, 48.28%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 4 people, 13.79%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 3.45%
Pancreatitis Chronic (chronic inflammation of pancreas): 1 person, 3.45%
Otitis Media (inflammation of the middle ear): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Avelox and have Deafness neurosensory?

- Check whether Deafness neurosensory is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Avelox:

Avelox (28,651 reports)

Browse all side effects of Avelox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Deafness neurosensory:

Deafness neurosensory (521 drugs)

Browse all the conditions that are associated with Deafness neurosensory:

Deafness neurosensory (947 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on moxifloxacin hydrochloride (the active ingredients of Avelox) and Avelox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.